Skip to content

Clinical Study of the Topcon Pachymeter TRK-3 to Evaluate Agreement and Precision

Clinical Study of the Topcon Pachymeter TRK-3 to Evaluate Agreement and Precision

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05283343
Enrollment
30
Registered
2022-03-16
Start date
2021-11-27
Completion date
2021-11-27
Last updated
2022-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal Thickness

Brief summary

Agreement and Precision of corneal thickness measurement (pachymetry) function of the test device TRK-3 and the predicate device SP-1P will be evaluated in volunteers, and safety will be evaluated.

Interventions

DEVICESP-1P

A subject undergoes corneal thickness measurement with pachymeter.

Sponsors

Topcon Corporation
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Individuals who gave written informed consent to participate in the clinical trial by their free will. 2. Individuals who aged 20 years or older at the time of informed consent 3. Individuals who were deemed eligible for the study by the investigator for screening prior to enrollment. 4. Subjects who are able to comply with compliance items during participation in the clinical trial, undergo medical examination and examination specified in the protocol, and report subjective symptoms, etc.

Exclusion criteria

1. Individuals with ocular diseases that may affect corneal thickness measurement (blindness, corneal perforation, bullous keratopathy, nystagmus, etc.) or who have a history of ocular diseases and are considered by the investigator to be ineligible for participation in the study. 2. Individuals who have or are suspected of suffering from ocular or systemic infections. 3. Other persons who are judged by the investigator to be unfavorable candidates for the study.

Design outcomes

Primary

MeasureTime frameDescription
Corneal thickness1 dayCorneal thickness

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026